Living Donor Hepatectomies with Procedures to Prevent Biliary Complications
Akinobu Taketomi(Hokkaido University), Y. Maehara(Kyushu University), Yuji Soejima(Shinshu University), Hideaki Uchiyama(Kyushu University), Kazuki Takeishi(University of Pittsburgh), Mizuki Ninomiya(Kyushu University), Takeo Toshima(Kyushu University Hospital), Kazutoyo Morita(Kyushu University), Hiroto Kayashima(Kyushu University), Ken Shirabe(Gunma University)
Cited by 62
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244